CT, NG and TV coinfection* positivity by age group and sex
| CT coinfections | NG coinfections | TV coinfections | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CT pos | CT, % with NG | CT, % with TV | NG pos | NG, % with CT | NG, % with TV* | TV pos | TV, % with CT* | TV, % with NG* | ||||||||
| n | n | % (95% CI) | N | % (95% CI) | n | n | % (95% CI) | N | % (95% CI) | n | n | % (95%CI) | n | % (95%CI) | ||
| Overall | 1547 | 482 | 31.2 (28.9 to 33.6) | 380 | 24.6 (22.5 to 26.9) | 1361 | 463 | 34.0 (31.5 to 36.6) | 354 | 26.0 (23.7 to 28.4) | 2367 | 326 | 13.8 (12.4 to 15.3) | 309 | 13.1 (11.7 to 14.5) | |
| Sex | Men | 501 | 219 | 43.7 (39.3 to 48.2) | 42 | 8.4 (6.1 to 11.2) | 565 | 191 | 33.8 (30.0 to 37.9) | 41 | 7.3 (5.3 to 9.7) | 333 | 35 | 10.5 (7.4 to 14.3) | 45 | 13.5 (10.0 to 17.7) |
| Women | 1046 | 263 | 25.1 (22.5 to 27.9) | 338 | 32.3 (29.5 to 35.2) | 796 | 272 | 34.2 (30.9 to 37.6) | 313 | 39.3 (36.0 to 42.8) | 2034 | 291 | 14.3 (12.8 to 15.9) | 264 | 13.0 (11.5 to 14.5) | |
| Men | 16–19 | 153 | 83 | 54.2 (46.0 to 62.3) | 16 | 10.5 (6.1 to 16.4) | 173 | 70 | 40.5 (33.1 to 48.2) | 13 | 7.5 (4.1 to 12.5) | 47 | 14 | 29.8 (17.3 to 44.9) | 15 | 31.9 (19.1 to 47.1) |
| 20–24 | 157 | 73 | 46.5 (38.5 to 54.6) | 12 | 7.6 (4.0 to 13.0) | 173 | 62 | 35.8 (28.7 to 43.5) | 13 | 7.5 (2.7 to 17.8) | 51 | 9 | 17.6 (8.4 to 30.9) | 15 | 29.4 (17.5 to 43.8) | |
| 25–29 | 87 | 31 | 35.6 (25.6 to 46.6) | 6 | 6.9 (2.6 to 14.4) | 98 | 28 | 28.6 (19.9 to 38.6) | 5 | 5.1 (1.7 to 11.5) | 55 | 4 | 7.3 (2.0 to 17.6) | 6 | 10.9 (0.4 to 22.2) | |
| 30–34 | 49 | 20 | 40.8 (27.0 to 55.8) | 2 | 4.1 (0.4 to 14.0) | 59 | 19 | 32.2 (20.6 to 45.6) | 3 | 5.1 (1.1 to 14.1) | 36 | 2 | 5.6 (0.7 to 18.7) | 3 | 8.3 (1.8 to 22.5) | |
| 35+ | 55 | 12 | 21.8 (11.8 to 35.0) | 6 | 10.9 (4.0 to 22.2) | 62 | 12 | 19.4 (10.4 to 31.4) | 7 | 11.3 (4.7 to 21.9) | 144 | 6 | 4.2 (1.5 to 8.8) | 6 | 4.2 (1.5 to 8.8) | |
| Women | 16–19 | 340 | 97 | 28.5 (23.8 to 33.6) | 131 | 38.5 (33.3 to 43.9) | 273 | 106 | 38.8 (33.0 to 44.9) | 111 | 40.7 (34.8 to 46.7) | 430 | 123 | 28.6 (24.4 to 33.1) | 95 | 22.1 (18.3 to 26.3) |
| 20–24 | 339 | 110 | 32.4 (27.5 to 37.7) | 108 | 31.9 (26.9 to 37.1) | 268 | 110 | 41.0 (35.1 to 47.2) | 111 | 41.4 (35.5 to 47.6) | 458 | 88 | 19.2 (15.7 to 23.1) | 94 | 20.5 (16.9 to 24.5) | |
| 25–29 | 178 | 32 | 18.0 (12.6 to 24.4) | 49 | 27.5 (21.1 to 34.7) | 111 | 34 | 30.6 (22.2 to 40.1) | 44 | 39.6 (30.5 to 49.4) | 314 | 39 | 12.4 (8.9 to 16.6) | 35 | 11.1 (7.9 to 15.2) | |
| 30–34 | 76 | 13 | 17.1 (9.4 to 27.5) | 25 | 32.9 (22.5 to 44.6) | 73 | 12 | 16.4 (8.8-.27.0) | 23 | 31.5 (21.1 to 43.4) | 223 | 18 | 8.1 (4.9 to 12.5) | 20 | 9.0 (5.6 to 13.5) | |
| 35+ | 113 | 11 | 9.7 (5.0 to 16.8) | 25 | 22.1 (14.9 to 30.9) | 71 | 10 | 14.1 (7.0 to 24.4) | 24 | 33.8 (23.0 to 46.0) | 609 | 34 | 5.6 (3.9 to 7.7) | 20 | 3.3 (2.0 to 5.0) | |
*Coinfection: proportion of unique patients who tested positive for one infection, with a positive result for another infection.
CT, Chlamydia trachomatis; NG, Neisseria gonorrhoea; TV, Trichomonas vaginalis.